drugset / Trial / NCT02648503
Deep Neuromuscular Block and Sugammadex Versus Standard of Care on Quality of Recovery in Patient Undergo Elective Laparoscopic Cholecystectomy
Phase 4
Unknown
120 enrolled
University of Medicine and Pharmacy at Ho Chi Minh City
Merck Sharp & Dohme LLC · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
Single center, prospective, randomized, single blinded, parallel group and controlled, assessor-blinded trial to compare the impact of Deep neuromuscular block and Sugammadex versus Standard of care on Quality of recovery in patient undergo elective laparoscopic cholecystectomy using PQRS at different time-point: 15 minutes (T15), 40 minutes (T40), one(D1) and three(D3) days after surgery
Timeline
- Start
- 2016-03
- Primary completion
- 2016-09
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Neostigmine | Other / unclassified | 1 mg | — |
| Comparator | Neostigmine | Other / unclassified | 2 mg | — |
| Subject | Sugammadex | Other / unclassified | — | — |
| Comparator | Atropine | Other / unclassified | 0.5 mg | — |
| Comparator | Atropine | Other / unclassified | 1 mg | — |
| Background | Rocuronium | Other / unclassified | 0.075 mg/kg | — |
| Background | Rocuronium | Other / unclassified | 0.15 mg/kg | — |